Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Sahar M El-Haggar, Sahar K Hegazy, Sherief M Abd-Elsalam, Eslam B Elkaeed, Ahmed A Al-Karmalawy & Mostafa M Bahaa. (2022) RETRACTED ARTICLE: A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Inflammation Research 15, pages 1159-1172.
Read now
Read now
Annett Maderer, Frederic Fiteni, Erik Tanis, Murielle Mauer, Thomas Schmitt, Daniela E. Aust, Manfred P. Lutz, Felicitas Roelofson, Christiane Gog, Arndt Weinmann, Claus H. Koehne, Markus Moehler & Thomas Thomaidis. (2021) CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset. Acta Oncologica 60:11, pages 1543-1547.
Read now
Read now
Pasquale Cutolo, Nathalie Basdevant, Guillaume Bernadat, Françoise Bachelerie & Tâp Ha-Duong. (2017) Interaction of chemokine receptor CXCR4 in monomeric and dimeric state with its endogenous ligand CXCL12: coarse-grained simulations identify differences. Journal of Biomolecular Structure and Dynamics 35:2, pages 399-412.
Read now
Read now
Aitziber Buqué, Norma Bloy, Fernando Aranda, Isabelle Cremer, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy. OncoImmunology 5:6.
Read now
Read now
Ruiwan Chen, Yafei Xu, Xiaojing Du, Na Liu, Yingqin Li, Qingmei He, Linglong Tang, Yanping Mao, Ying Sun, Lei Chen & Jun Ma. (2015) CXCL12 genetic variants as prognostic markers in nasopharyngeal carcinoma. OncoTargets and Therapy 8, pages 2835-2842.
Read now
Read now
Monica Cojoc, Claudia Peitzsch, Franziska Trautmann, Leo Polishchuk, Gennady D Telegeev & Anna Dubrovska. (2013) Emerging targets in cancer management: role of the CXCL12/CXCR4 axis. OncoTargets and Therapy 6, pages 1347-1361.
Read now
Read now
Ugutz Unzueta, María Virtudes Céspedes, Neus Ferrer-Miralles, Isolda Casanova, Juan Cedano, José Luis Corchero, Joan Domingo-Espín, Antonio Villaverde, Ramón Mangues & Esther Vázquez. (2012) Intracellular CXCR4+ cell targeting with T22-empowered protein-only nanoparticles. International Journal of Nanomedicine 7, pages 4533-4544.
Read now
Read now
Articles from other publishers (63)
Mahvash Sadeghi, Sajad Dehnavi, Ali Asadirad, Suowen Xu, Muhammed Majeed, Tannaz Jamialahmadi, Thomas P. Johnston & Amirhossein Sahebkar. (2023) Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases. Inflammopharmacology 31:3, pages 1069-1093.
Crossref
Crossref
Hee-Kyung Park, Lan Phuong Nguyen, Thai Uy Nguyen, Minyeong Cho, Huong Thi Nguyen, Sunghoon Hurh, Hong-Rae Kim, Jae Young Seong, Cheol Soon Lee, Byung-Joo Ham & Jong-Ik Hwang. (2023) The N-terminus of CXCR4 splice variants determines expression and functional properties. PLOS ONE 18:5, pages e0283015.
Crossref
Crossref
Tatiana S. Gerashchenko, Anastasia A. Schegoleva, Anna A. Khozyainova, Evgeny L. Choinzonov & Evgeny V. Denisov. (2023) Metastasis prevention: How to catch metastatic seeds. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:3, pages 188867.
Crossref
Crossref
Sebastian DekkersBirgit CasparJoëlle Goulding, Nicholas D. KindonLaura E. Kilpatrick, Leigh A. StoddartStephen J. BriddonBarrie Kellam, Stephen J. Hill & Michael J. Stocks. (2023) Small-Molecule Fluorescent Ligands for the CXCR4 Chemokine Receptor. Journal of Medicinal Chemistry.
Crossref
Crossref
Yangjin Kim, Junho Lee, Chaeyoung Lee & Sean Lawler. (2022) Role of senescent tumor cells in building a cytokine shield in the tumor microenvironment: mathematical modeling. Journal of Mathematical Biology 86:1.
Crossref
Crossref
Md Sajedul Islam, Vinod Gopalan & Farhadul Islam. 2023. Cancer Stem Cells: Basic Concept and Therapeutic Implications. Cancer Stem Cells: Basic Concept and Therapeutic Implications
255
269
.
Sanaz Katal, Antonio Maldonado, Javier Carrascoso, Majid Assadi & Ali Gholamrezanezhad. (2021) Theranostic Agents in Musculoskeletal Disorders. PET Clinics 16:3, pages 441-448.
Crossref
Crossref
Wei Kang, Chuanfeng Ding, Danni Zheng, Xiao Ma, Lun Yi, Xinyi Tong, Chuang Wu, Chuang Xue, Yongsheng Yu & Qian Zhou. (2021) Nanobody Conjugates for Targeted Cancer Therapy and Imaging. Technology in Cancer Research & Treatment 20, pages 153303382110101.
Crossref
Crossref
James W. Murphy, Deepa Rajasekaran, Janie Merkel, Erin Skeens, Camille Keeler, Michael E. Hodsdon, George P. Lisi & Elias Lolis. (2020) High-Throughput Screening of a Functional Human CXCL12-CXCR4 Signaling Axis in a Genetically Modified S. cerevisiae: Discovery of a Novel Up-Regulator of CXCR4 Activity. Frontiers in Molecular Biosciences 7.
Crossref
Crossref
Xilun Anthony Wang, Katherine Griffiths & Michael Foley. 2020. Anti-fibrotic Drug Discovery. Anti-fibrotic Drug Discovery
211
234
.
Surinder M. Soond & Andrey A. ZamyatninJr.Jr.. 2020. GPCR Signaling in Cancer. GPCR Signaling in Cancer
49
97
.
Martine J. Smit & Jacqueline E. van Muijlwijk-Koezen. (2019) From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function. Molecular Pharmacology 96:6, pages 735-736.
Crossref
Crossref
Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard & Martine J. Smit. (2019) Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3. Molecular Pharmacology 96:6, pages 753-764.
Crossref
Crossref
Kentaro Suzuki, Takashi Ui, Akio Nagano, Akihiro Hino & Yasushi Arano. (2019) C-terminal–modified LY2510924: a versatile scaffold for targeting C-X-C chemokine receptor type 4. Scientific Reports 9:1.
Crossref
Crossref
Weiqiang Zhou, Shanchun Guo, Mingli Liu, Matthew E. Burow & Guangdi Wang. (2019) Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy. Current Medicinal Chemistry 26:17, pages 3026-3041.
Crossref
Crossref
Huy H. Nguyen, Michelle B. Kim, Robert J. Wilson, Christopher J. Butch, Katie M. Kuo, Eric J. Miller, Yesim A. Tahirovic, Edgars Jecs, Valarie M. Truax, Tao Wang, Chi S. Sum, Mary E. Cvijic, Gretchen M. Schroeder, Lawrence J. Wilson & Dennis C. Liotta. (2018) Design, Synthesis, and Pharmacological Evaluation of Second-Generation Tetrahydroisoquinoline-Based CXCR4 Antagonists with Favorable ADME Properties. Journal of Medicinal Chemistry 61:16, pages 7168-7188.
Crossref
Crossref
Shiri Klein, Michal Abraham, Baruch Bulvik, Elia Dery, Ido D. Weiss, Neta Barashi, Rinat Abramovitch, Hanna Wald, Yaniv Harel, Devorah Olam, Lola Weiss, Katia Beider, Orly Eizenberg, Ori Wald, Eithan Galun, Yaron Pereg & Amnon Peled. (2018) CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1–Mediated ERK and BCL2/Cyclin D1 Pathways. Cancer Research 78:6, pages 1471-1483.
Crossref
Crossref
Ellen L. Weisberg, Martin Sattler, Abdel Kareem Azab, Dirk Eulberg, Anna Kruschinski, Paul W. Manley, Richard Stone & James D. Griffin. (2017) Inhibition of SDF-1-induced migration of oncogene-driven myeloid leukemia by the L-RNA aptamer (Spiegelmer), NOX-A12, and potentiation of tyrosine kinase inhibition. Oncotarget 8:66, pages 109973-109984.
Crossref
Crossref
M Abraham, S Klein, B Bulvik, H Wald, I D Weiss, D Olam, L Weiss, K Beider, O Eizenberg, O Wald, E Galun, A Avigdor, O Benjamini, A Nagler, Y Pereg, S Tavor & A Peled. (2017) The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression. Leukemia 31:11, pages 2336-2346.
Crossref
Crossref
Ido D. Weiss, Lyn M. Huff, Moses O. Evbuomwan, Xin Xu, Hong Duc Dang, Daniel S. Velez, Satya P. Singh, Hongwei H. Zhang, Paul J. Gardina, Jae-Ho Lee, Liza Lindenberg, Timothy G. Myers, Chang H. Paik, David S. Schrump, Stefania Pittaluga, Peter L. Choyke, Tito Fojo & Joshua M. Farber. (2017) Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET. Oncotarget 8:43, pages 73387-73406.
Crossref
Crossref
Andreas Riegger, Chaojian Chen, Onofrio Zirafi, Nora Daiss, Debashish Mukherji, Karolin Walter, Yu Tokura, Bettina Stöckle, Kurt Kremer, Frank Kirchhoff, David Yuen Wah Ng, Patrick Christian Hermann, Jan Münch & Tanja Weil. (2017) Synthesis of Peptide-Functionalized Poly(bis-sulfone) Copolymers Regulating HIV-1 Entry and Cancer Stem Cell Migration. ACS Macro Letters 6:3, pages 241-246.
Crossref
Crossref
Qingling Yang, Haihua Wu, Haifeng Wang, Yu Li, Lingyu Zhang, Lihua Zhu, Wenrui Wang, Jihong Zhou, Yingxiao Fu, Sulian Chen, Qiong Wu, Changjie Chen & Congzhao Zhou. (2017) N-terminal polypeptide derived from vMIP-II exerts its antitumor activity by inhibiting the CXCR4 pathway in human glioma. International Journal of Oncology.
Crossref
Crossref
Jatinder Singh, Ramanpreet Shah & Dhandeep Singh. (2016) Targeting mast cells: Uncovering prolific therapeutic role in myriad diseases. International Immunopharmacology 40, pages 362-384.
Crossref
Crossref
Zhidong Wang, Jian Sun, Yeqian Feng, Xiaocai Tian, Bin Wang & Yong Zhou. (2016) Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell. Tumor Biology 37:7, pages 8515-8528.
Crossref
Crossref
Peng Fu, Lin Tian, Xueliang Cao, Li Li, Peng Xu & Changjiu Zhao. (2015) Imaging CXCR4 Expression with 99mTc-Radiolabeled Small-Interference RNA in Experimental Human Breast Cancer Xenografts. Molecular Imaging and Biology 18:3, pages 353-359.
Crossref
Crossref
Zeng-hui Cheng, Yu-xin Shi, Min Yuan, Dan Xiong, Jiang-hua Zheng & Zhi-yong Zhang. (2016) Chemokines and their receptors in lung cancer progression and metastasis趋化因子及其受体在肺癌侵袭与转移过程中的作用. Journal of Zhejiang University-SCIENCE B 17:5, pages 342-351.
Crossref
Crossref
Francesca Chiarini, Annalisa Lonetti, Camilla Evangelisti, Francesca Buontempo, Ester Orsini, Cecilia Evangelisti, Alessandra Cappellini, Luca M. Neri, James A. McCubrey & Alberto M. Martelli. (2016) Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1863:3, pages 449-463.
Crossref
Crossref
Vivek Mittal. 2016. Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management. Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management
37
56
.
Vittorio Emanuele Muccio, Elona Saraci, Milena Gilestro, Valter Gattei, Antonella Zucchetto, Monica Astolfi, Marina Ruggeri, Eleonora Marzanati, Roberto Passera, Antonio Palumbo, Mario Boccadoro & Paola Omedè. (2016) Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents. Cytometry Part B: Clinical Cytometry 90:1, pages 81-90.
Crossref
Crossref
R Muralidharan, J Panneerselvam, A Chen, Y D Zhao, A Munshi & R Ramesh. (2015) HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer. Cancer Gene Therapy 22:12, pages 581-590.
Crossref
Crossref
Jingyu Xiang, Michelle A. Hurchla, Francesca Fontana, Xinming Su, Sarah R. Amend, Alison K. Esser, Garry J. Douglas, Chidananda Mudalagiriyappa, Kathryn E. Luker, Timothy Pluard, Foluso O. Ademuyiwa, Barbara Romagnoli, Gérald Tuffin, Eric Chevalier, Gary D. Luker, Michael Bauer, Johann Zimmermann, Rebecca L. Aft, Klaus Dembowsky & Katherine N. Weilbaecher. (2015) CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer. Molecular Cancer Therapeutics 14:11, pages 2473-2485.
Crossref
Crossref
Huanyu Zhao, Anthony R. Prosser, Dennis C. Liotta & Lawrence J. Wilson. (2015) Discovery of novel N-aryl piperazine CXCR4 antagonists. Bioorganic & Medicinal Chemistry Letters 25:21, pages 4950-4955.
Crossref
Crossref
Haiou Liu, Yidong Liu, Weisi Liu, Weijuan Zhang & Jiejie Xu. (2015) EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma. Nature Communications 6:1.
Crossref
Crossref
Martha Gschwandtner, Martin U. Trinker, Bianca Hecher, Tiziana Adage, Simi Ali & Andreas J. Kungl. (2015) Glycosaminoglycan silencing by engineered CXCL12 variants. FEBS Letters 589:19PartB, pages 2819-2824.
Crossref
Crossref
L. Wang, F. Du, H.M. Zhang, W.J. Zhang & H.X. Wang. (2015) Changes in circulating endothelial progenitor cells predict responses of multiple myeloma patients to treatment with bortezomib and dexamethasone. Brazilian Journal of Medical and Biological Research 48:8, pages 736-742.
Crossref
Crossref
Onofrio Zirafi, Kyeong-Ae Kim, Ludger Ständker, Katharina B. Mohr, Daniel Sauter, Anke Heigele, Silvia F. Kluge, Eliza Wiercinska, Doreen Chudziak, Rudolf Richter, Barbara Moepps, Peter Gierschik, Virag Vas, Hartmut Geiger, Markus Lamla, Tanja Weil, Timo Burster, Andreas Zgraja, Francois Daubeuf, Nelly Frossard, Muriel Hachet-Haas, Fabian Heunisch, Christoph Reichetzeder, Jean-Luc Galzi, Javier Pérez-Castells, Angeles Canales-Mayordomo, Jesus Jiménez-Barbero, Guillermo Giménez-Gallego, Marion Schneider, James Shorter, Amalio Telenti, Berthold Hocher, Wolf-Georg Forssmann, Halvard Bonig, Frank Kirchhoff & Jan Münch. (2015) Discovery and Characterization of an Endogenous CXCR4 Antagonist. Cell Reports 11:5, pages 737-747.
Crossref
Crossref
Debananda Das, Kenji Maeda, Yasuhiro Hayashi, Navnath Gavande, Darshan V. Desai, Simon B. Chang, Arun K. Ghosh & Hiroaki Mitsuya. (2015) Insights into the Mechanism of Inhibition of CXCR4: Identification of Piperidinylethanamine Analogs as Anti-HIV-1 Inhibitors. Antimicrobial Agents and Chemotherapy 59:4, pages 1895-1904.
Crossref
Crossref
Janani Panneerselvam, Jiankang Jin, Manish Shanker, Jason Lauderdale, Jonathan Bates, Qi Wang, Yan D. Zhao, Stephen J. Archibald, Timothy J. Hubin & Rajagopal Ramesh. (2015) IL-24 Inhibits Lung Cancer Cell Migration and Invasion by Disrupting The SDF-1/CXCR4 Signaling Axis. PLOS ONE 10:3, pages e0122439.
Crossref
Crossref
James G. MacKrell, Benjamin C. Yaden, Heather Bullock, Keyue Chen, Pamela Shetler, Henry U. Bryant & Venkatesh Krishnan. (2018) Molecular Targets of Androgen Signaling that Characterize Skeletal Muscle Recovery and Regeneration. Nuclear Receptor Signaling 13:1, pages nrs.13005.
Crossref
Crossref
Johanna Sandgren, Stefan Holm, Ana Maria Marino, Jurate Asmundsson, Pernilla Grillner, Monica Nistér & Teresita Díaz de Ståhl. (2015)
Whole Exome- and mRNA-Sequencing of an AT/RT Case Reveals Few Somatic Mutations and Several Deregulated Signalling Pathways in the Context of
SMARCB1
Deficiency
. BioMed Research International 2015, pages 1-12.
Crossref
Crossref
Sarah E. NeweyGrigorios TsaknakisCheen P. KhooThanassi AthanassopoulosRosalba CamiciaYouyi ZhangRita GrabowskaAdrian L. HarrisMaria G. RoubelakisSuzanne M. Watt. (2014) The Hematopoietic Chemokine CXCL12 Promotes Integration of Human Endothelial Colony Forming Cell–Derived Cells into Immature Vessel Networks. Stem Cells and Development 23:22, pages 2730-2743.
Crossref
Crossref
Angeles Alvarez Secord, Andrew B. Nixon & Herbert I. Hurwitz. (2014) The search for biomarkers to direct antiangiogenic treatment in epithelial ovarian cancer. Gynecologic Oncology 135:2, pages 349-358.
Crossref
Crossref
Philipp Ermert, Kerstin Moehle & Daniel Obrecht. 2014. Macrocycles in Drug Discovery. Macrocycles in Drug Discovery
283
338
.
Polina Weitzenfeld & Adit Ben-Baruch. (2014) The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer. Cancer Letters 352:1, pages 36-53.
Crossref
Crossref
Kuan-Min Fang, Chung-Shi Yang, Tzu-Chien Lin, Ti-Chun Chan & Shun-Fen Tzeng. (2014) Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells. Neuro-Oncology 16:4, pages 552-566.
Crossref
Crossref
Q Yang, F Zhang, Y Ding, J Huang, S Chen, Q Wu, Z Wang, Z Wang & C Chen. (2014) Antitumour activity of the recombination polypeptide GST-NT21MP is mediated by inhibition of CXCR4 pathway in breast cancer. British Journal of Cancer 110:5, pages 1288-1297.
Crossref
Crossref
Julia Hoellenriegel, Dirk Zboralski, Christian Maasch, Nathalie Y. Rosin, William G. Wierda, Michael J. Keating, Anna Kruschinski & Jan A. Burger. (2014) The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization. Blood 123:7, pages 1032-1039.
Crossref
Crossref
Tao Wang, Yanfang Mi, Linping Pian, Ping Gao, Hong Xu, Yuling Zheng & Xiaoyan Xuan. (2013) RETRACTED ARTICLE: RNAi targeting CXCR4 inhibits proliferation and invasion of esophageal carcinoma cells. Diagnostic Pathology 8:1.
Crossref
Crossref
Monica Gatti, Alessandra Pattarozzi, Adriana Bajetto, Roberto Würth, Antonio Daga, Pietro Fiaschi, Gianluigi Zona, Tullio Florio & Federica Barbieri. (2013) Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity. Toxicology 314:2-3, pages 209-220.
Crossref
Crossref
Valarie M. Truax, Huanyu Zhao, Brooke M. Katzman, Anthony R. Prosser, Ana A. Alcaraz, Manohar T. Saindane, Randy B. Howard, Deborah Culver, Richard F. Arrendale, Prahbakar R. Gruddanti, Taylor J. Evers, Michael G. Natchus, James P. Snyder, Dennis C. Liotta & Lawrence J. Wilson. (2013) Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists. ACS Medicinal Chemistry Letters 4:11, pages 1025-1030.
Crossref
Crossref
Michal Abraham, Ido D. Weiss, Hanna Wald, Ori Wald, Arnon Nagler, Katia Beider, Orly Eizenberg & Amnon Peled. (2013)
Sequential administration of the high affinity
CXCR
4 antagonist
BKT
140 promotes megakaryopoiesis and platelet production
. British Journal of Haematology 163:2, pages 248-259.
Crossref
Crossref
Cuiling Zhong, Jianyong Wang, Bing Li, Hong Xiang, Mark Ultsch, Mary Coons, Terence Wong, Nancy Y. Chiang, Suzy Clark, Robyn Clark, Leah Quintana, Peter Gribling, Eric Suto, Kai Barck, Racquel Corpuz, Jenny Yao, Rashi Takkar, Wyne P. Lee, Lisa A. Damico-Beyer, Richard D. Carano, Camellia Adams, Robert F. Kelley, Weiru Wang & Napoleone Ferrara. (2013) Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL12. Clinical Cancer Research 19:16, pages 4433-4445.
Crossref
Crossref
Wenli Zheng, Dingshen Liu, Xiangshan Fan, Linda Powers, Maitrayee Goswami, Ying Hu, Pei Lin, L. Jeffrey Medeiros & Sa A. Wang. (2013) Potential therapeutic biomarkers in plasma cell myeloma: A flow cytometry study. Cytometry Part B: Clinical Cytometry 84B:4, pages 222-228.
Crossref
Crossref
Tadashi Nakasone, Sei Kumakura, Michiko Yamamoto, Tsutomu Murakami & Naoki Yamamoto. (2012) Single oral administration of the novel CXCR4 antagonist, KRH-3955, induces an efficient and long-lasting increase of white blood cell count in normal macaques, and prevents CD4 depletion in SHIV-infected macaques: a preliminary study. Medical Microbiology and Immunology 202:2, pages 175-182.
Crossref
Crossref
. (2013) Current World Literature. Current Opinion in Oncology 25:2, pages 205-212.
Crossref
Crossref
Wei Mo, Jian Chen, Amish Patel, Liang Zhang, Vincent Chau, Yanjiao Li, Woosung Cho, Kyun Lim, Jing Xu, Alexander J. Lazar, Chad J. Creighton, Svetlana Bolshakov, Renée M. McKay, Dina Lev, Lu Q. Le & Luis F. Parada. (2013) CXCR4/CXCL12 Mediate Autocrine Cell- Cycle Progression in NF1-Associated Malignant Peripheral Nerve Sheath Tumors. Cell 152:5, pages 1077-1090.
Crossref
Crossref
Deborah M. Ramsey & Shelli R. McAlpine. (2013) Halting metastasis through CXCR4 inhibition. Bioorganic & Medicinal Chemistry Letters 23:1, pages 20-25.
Crossref
Crossref
Shishir Shishodia. (2013) Molecular mechanisms of curcumin action: Gene expression. BioFactors 39:1, pages 37-55.
Crossref
Crossref
Filippo Casoni, B. Ian Hutchins, Duncan Donohue, Michele Fornaro, Brian G. Condie & Susan Wray. (2012) SDF and GABA interact to regulate axophilic migration of GnRH neurons. Journal of Cell Science 125:21, pages 5015-5025.
Crossref
Crossref
Duha Fahham, Ido D. Weiss, Michal Abraham, Katia Beider, Wald Hanna, Zippora Shlomai, Orly Eizenberg, Gideon Zamir, Uzi Izhar, Oz M. Shapira, Amnon Peled & Ori Wald. (2012) In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non–small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery 144:5, pages 1167-1175.e1.
Crossref
Crossref
Huanhuan Joyce Chen, Robert Edwards, Serena Tucci, Pengcheng Bu, Jeff Milsom, Sang Lee, Winfried Edelmann, Zeynep H. Gümüs, Xiling Shen & Steven Lipkin. (2012) Chemokine 25–induced signaling suppresses colon cancer invasion and metastasis. Journal of Clinical Investigation 122:9, pages 3184-3196.
Crossref
Crossref
Albert Zlotnik & Osamu Yoshie. (2012) The Chemokine Superfamily Revisited. Immunity 36:5, pages 705-716.
Crossref
Crossref
Joeri Kuil, Tessa Buckle & Fijs W. B. van Leeuwen. (2012) Imaging agents for the chemokine receptor 4 (CXCR4). Chemical Society Reviews 41:15, pages 5239.
Crossref
Crossref